The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells

[1]  淳一 佐々木.  Air Force/Texas Coronary Atherosclerosis Prevention Study , 2008 .

[2]  Hermann Brenner,et al.  Individual and joint use of statins and low‐dose aspirin and risk of colorectal cancer: A population‐based case–control study , 2007, International journal of cancer.

[3]  G. Caldito,et al.  Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. , 2007, Chest.

[4]  Andrew J. Brown.  CHOLESTEROL, STATINS AND CANCER , 2007, Clinical and experimental pharmacology & physiology.

[5]  D. Miglioretti,et al.  Statin Use and Breast Cancer Risk in a Large Population-Based Setting , 2007, Cancer Epidemiology Biomarkers & Prevention.

[6]  Scott R. Freeman,et al.  Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. , 2006, Journal of the National Cancer Institute.

[7]  Michael J Thun,et al.  Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. , 2006, Journal of the National Cancer Institute.

[8]  S. Bonovas,et al.  Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A Heather Eliassen,et al.  Serum lipids, lipid-lowering drugs, and the risk of breast cancer. , 2005, Archives of internal medicine.

[10]  M. Shehata,et al.  Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells , 2005, Cancer Cell International.

[11]  R. Dellavalle,et al.  Lovastatin-induced apoptosis in human melanoma cell lines , 2005, Melanoma research.

[12]  S. Sleijfer,et al.  The potential of statins as part of anti-cancer treatment. , 2005, European journal of cancer.

[13]  Henk-Jan Guchelaar,et al.  Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer. , 2004, Cancer treatment reviews.

[14]  M. Clynes,et al.  A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin , 2004, British Journal of Cancer.

[15]  M. Trikha,et al.  CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo , 2004, International journal of cancer.

[16]  Henk-Jan Guchelaar,et al.  The risk of cancer in users of statins. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Merajver,et al.  Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. , 2003, Molecular cancer therapeutics.

[18]  N. Idkaidek,et al.  Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast & Zocor) in healthy human volunteers , 2003, Biopharmaceutics & drug disposition.

[19]  D. Wallwiener,et al.  Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells , 2003, Menopause.

[20]  M. Hendrix,et al.  Molecular plasticity of human melanoma cells , 2003, Oncogene.

[21]  D. Wallwiener,et al.  Statins can inhibit proliferation of human breast cancer cells in vitro. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[22]  G. Korczak-Kowalska,et al.  Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis‐dependent mechanism , 2002, International journal of cancer.

[23]  C. Elson,et al.  Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. , 1999, Journal of NutriLife.

[24]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[25]  J. Gołąb,et al.  Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice. , 1998, European journal of cancer.

[26]  T. Akasaka,et al.  Attachment, spreading and migration of melanoma cells on vitronectin , 1996, Experimental dermatology.

[27]  D. Samid,et al.  Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  W C Willett,et al.  Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.

[29]  L. Liotta,et al.  Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.

[30]  M. Clynes,et al.  Acid phosphatase: Endpoint for in vitro toxicity tests , 1991, In Vitro Cellular & Developmental Biology - Animal.

[31]  C Michael White,et al.  Statins and Cancer Risk: A Meta-analysis , 2007 .

[32]  R. van der Griend,et al.  Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. , 2006, Haematologica.

[33]  F. Maquart,et al.  Control of melanoma cell invasion by type IV collagen. , 2005, Cancer detection and prevention.

[34]  H. Welch.  Statins and the risk of colorectal cancer. , 2005, The New England journal of medicine.

[35]  D. Gomez,et al.  Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells , 2004, Clinical & Experimental Metastasis.

[36]  J. Turgeon,et al.  Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. , 1998, Trends in pharmacological sciences.

[37]  P. Quax,et al.  Properties of metastasizing and nonmetastasizing human melanoma cells. , 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.